India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

IT and Industries Minister D Sridhar Babu, made significant strides in international economic diplomacy on Saturday by ...

Telangana government opens dedicated desk for Swiss firms investing in India under TEPA, aiming to boost economic ties.

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...

The global Indian diaspora has consistently demonstrated its extraordinary talent and leadership across industries. The inaugural HSBC Hurun Global Indians List 2024 celebrates the achievements of ...

Novartis' CEO Vas Narasimhan on Tuesday ... underpinned by its research and development efforts in Hyderabad. The company’s strategy in India currently revolves around marketing tie-ups and ...

Mrudul Kumar said that over 350 Swiss companies like Nestle, Novartis and STMicroelectronics have set up their units in India providing 1.3 lakh jobs. Similarly, Indian-based companies like TCS, ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...